Literature DB >> 7815889

Look-back study of infectivity of anti-HCV ELISA-positive blood components.

H Vrielink1, C L van der Poel, H W Reesink, H L Zaaijer, E Scholten, L C Kremer, H T Cuypers, P N Lelie, M H van Oers.   

Abstract

The infectivity of blood components from donors who were later found to be anti-HCV ELISA-positive was investigated in recipients who were enrolled in a look-back programme. Recipients received ELISA-positive blood components from donors who were PCR-positive and/or RIBA-2-positive (n = 22, group A) or PCR-negative and indeterminate or negative on RIBA-2 (n = 105, group B). 26 of 32 (81%) recipients of group A donors and none of 140 of group B were HCV-infected. All stored serum samples of previous donations (n = 172) of group A donors were anti-HCV-positive in RIBA-3, indicating a chronic carrier state of HCV in these donors.

Entities:  

Mesh:

Year:  1995        PMID: 7815889     DOI: 10.1016/s0140-6736(95)90063-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

1.  Evaluation of performance of the RIBA processor system for automated analysis of the strip immunoblot assay for detection of antibodies to hepatitis C virus.

Authors:  G Icardi; P Bonanni; A M Raffo; A Masini; L Orione; M De Martini; P Crovari
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

Review 2.  Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups.

Authors:  H L Tillmann; M P Manns
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

3.  Chronic hepatitis C in long term survivors of haematological malignancy treated in a single centre.

Authors:  J R Neilson; P Harrison; S J Skidmore; J A King; K E Collingham; D W Milligan
Journal:  J Clin Pathol       Date:  1996-03       Impact factor: 3.411

4.  Chronic hepatitis C viral infection among SLE patients: the significance of coexistence.

Authors:  Naim Mahroum; Ashraf Hejly; Shmuel Tiosano; Omer Gendelman; Doron Comaneshter; Arnon D Cohen; Howard Amital
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

5.  Hepatitis C virus infections in dialysis centers in The Netherlands: a national survey by serological and molecular methods.

Authors:  P M Schneeberger; I Keur; W van der Vliet; K van Hoek; H Boswijk; A M van Loon; W C van Dijk; R H Kauffmann; W Quint; L J van Doorn
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

Review 6.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

7.  Risk of hepatitis C virus (HCV) transmission by anti-HCV-negative blood components in Austria and Germany.

Authors:  J Riggert; D W Schwartz; A Uy; G Simson; F Jelinek; H Fabritz; W R Mayr; M Köhler
Journal:  Ann Hematol       Date:  1996-01       Impact factor: 3.673

8.  The Role of the Signal-to-Cutoff Ratio in Automated Anti-HCV Chemiluminescent Immunoassays by Referring to the Nucleic Acid Amplification Test and the Recombinant Immunoblot Assay.

Authors:  Moon Suk Choi; Kyunghoon Lee; Yun Ji Hong; Eun Young Song; Dal Sik Kim; Junghan Song
Journal:  Ann Lab Med       Date:  2018-09       Impact factor: 3.464

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.